
Results
8
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
8 companies
Apex Biotechnology
Market Cap: NT$3.3b
Researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide.
1733
NT$32.80
7D
1.9%
1Y
15.1%
BIONET
Market Cap: NT$5.0b
Provides cell therapy services in Taiwan and internationally.
1784
NT$95.00
7D
-5.0%
1Y
6.1%
ICARES Medicus
Market Cap: NT$4.1b
Engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally.
6612
NT$88.10
7D
-0.9%
1Y
-26.6%
WeLeader Biomedical
Market Cap: NT$3.4b
Operates as an agent and distributor of in vitro diagnostic products.
7713
NT$74.50
7D
-0.5%
1Y
4.6%
United Orthopedic
Market Cap: NT$12.1b
Engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania.
4129
NT$125.50
7D
-3.1%
1Y
25.9%
Bioteque
Market Cap: NT$8.9b
Manufactures and sells medical device in Asia, South America, North America, and internationally.
4107
NT$128.50
7D
5.8%
1Y
2.4%
Ever Fortune.AI
Market Cap: NT$6.3b
An cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China.
6841
NT$66.80
7D
4.0%
1Y
-13.9%
Universal Vision Biotechnology
Market Cap: NT$12.3b
Operates a chain of eye care clinics in Taiwan and China.
3218
NT$145.00
7D
3.6%
1Y
-33.2%